156 related articles for article (PubMed ID: 36210027)
101. Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
Al-Ramahi JS; Shahzad M; Nguyen A; Li K; Amin MK; Ahmed N; Lutfi F; DeJarnette S; Chaudhary SG; Bansal R; Abdelhakim H; Shune L; Abdallah AO; Singh AK; Abhyankar SH; McGuirk JP; Mushtaq MU
Bone Marrow Transplant; 2024 Jan; 59(1):134-137. PubMed ID: 37833526
[No Abstract] [Full Text] [Related]
102. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
Luft T; Dreger P; Radujkovic A
Bone Marrow Transplant; 2021 Oct; 56(10):2326-2335. PubMed ID: 34253879
[TBL] [Abstract][Full Text] [Related]
103. Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.
Zinter MS; Brazauskas R; Strom J; Chen S; Bo-Subait S; Sharma A; Beitinjaneh A; Dimitrova D; Guilcher G; Preussler J; Myers K; Bhatt NS; Ringden O; Hematti P; Hayashi RJ; Patel S; De Oliveira SN; Rotz S; Badawy SM; Nishihori T; Buchbinder D; Hamilton B; Savani B; Schoemans H; Sorror M; Winestone L; Duncan C; Phelan R; Dvorak CC
Blood Adv; 2024 Feb; 8(4):1002-1017. PubMed ID: 38127268
[TBL] [Abstract][Full Text] [Related]
104. Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome.
Katzerke C; Schaffrath J; Lützkendorf J; Janssen M; Merbach AK; Nerger K; Binder M; Baum C; Lauer K; Rohde C; Willscher E; Müller-Tidow C; Müller LP
Blood Adv; 2023 Jun; 7(12):2811-2824. PubMed ID: 36763527
[TBL] [Abstract][Full Text] [Related]
105. Risk Factors for Graft-Versus-Host Disease and Survival in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience.
Bedir Demirdağ T; Kurşun Ağlamiş G; Kirkiz Kayal S; Uğraş Dikmen A; Kaya Z; Yenicesu İ; Koçak Ü
Exp Clin Transplant; 2021 Nov; ():. PubMed ID: 34775938
[TBL] [Abstract][Full Text] [Related]
106. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
Satty AM; Klein E; Mauguen A; Kunvarjee B; Boelens JJ; Cancio M; Curran KJ; Kernan NA; Prockop SE; Scaradavou A; Spitzer B; Tamari R; Ruggiero J; Torok-Castanza J; Mehta PA; O'Reilly RJ; Boulad F
Bone Marrow Transplant; 2024 Jan; 59(1):23-33. PubMed ID: 37773270
[TBL] [Abstract][Full Text] [Related]
107. CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature.
Bowman S; Stanek J; Bajwa R; Polishchuk V; Abu-Arja R; Rangarajan HG
Clin Hematol Int; 2023 Jun; 5(2-3):155-164. PubMed ID: 37027103
[TBL] [Abstract][Full Text] [Related]
108. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
109. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
Fraint E; Farooki S; Klein E; Mauguen A; Prockop SE; Scaradavou A; Curran K; Cancio M; Spitzer B; Boelens JJ; Oved J; Harris A; O'Reilly RJ; Kernan NA
Transplant Cell Ther; 2023 Jan; 29(1):46.e1-46.e6. PubMed ID: 36210027
[TBL] [Abstract][Full Text] [Related]
110. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
111. Fresh or Cryopreserved CD34
Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
[TBL] [Abstract][Full Text] [Related]
112. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
Larocca A; Piaggio G; Podestà M; Pitto A; Bruno B; Di Grazia C; Gualandi F; Occhini D; Raiola AM; Dominietto A; Bregante S; Lamparelli T; Tedone E; Oneto R; Frassoni F; Van Lint MT; Pogliani E; Bacigalupo A
Haematologica; 2006 Jul; 91(7):935-40. PubMed ID: 16818281
[TBL] [Abstract][Full Text] [Related]
113. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
[TBL] [Abstract][Full Text] [Related]
114. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
Kawano Y; Takaue Y; Watanabe A; Takeda O; Arai K; Itoh E; Ohno Y; Teshima T; Harada M; Watanabe T; Okamoto Y; Abe T; Kajiume T; Matsushita T; Ikeda K; Endo M; Kuroda Y; Asano S; Tanosaki R; Yamaguchi K; Law P; McMannis JD
Blood; 1998 Nov; 92(9):3123-30. PubMed ID: 9787147
[TBL] [Abstract][Full Text] [Related]
115. Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.
Prabahran A; Koldej R; Chee L; Ritchie D
Blood Adv; 2022 Mar; 6(6):1947-1959. PubMed ID: 34492685
[TBL] [Abstract][Full Text] [Related]
116.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
117.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
